Insider · CIK 0001180679

SHARROCK DAVID B

Reports to the SEC for 6 companies · CINCINNATI, OH

sec.gov

Transactions

Companies

Filings

CIK

0001180679

Forms 4 and 5

Insider transactions

48 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2008-01-23	MGI PHARMA INCU Disposition from Tender	Director	UDisposition from Tender	−6,000 sh	$41.00	−$246K	0
2007-05-08	MGI PHARMA INCDirector Stock Option - Right to BuyA Award	Director	AAward	+15K sh	$21.87	+$328K	15,000
2006-04-28	CINCINNATI BELL INCOption to BuyA Award	Director	AAward	+9,000 sh	—	—	9,000
2005-04-29	CINCINNATI BELL INCOption to BuyA Award	Director	AAward	+9,000 sh	—	—	9,000
2005-01-03	CINCINNATI BELL INCPhantom SharesA Award	Director	AAward	+6,000 sh	—	—	31,895.621
2004-10-04	Endo Pharmaceuticals Solutions Inc.S Sale	Director	SSale	−8,010 sh	$7.18	−$57.5K	5,000
2004-10-01	Endo Pharmaceuticals Solutions Inc.A Award	Director	AAward	+50K sh	$2.38	+$119K	55,000
2004-10-01	Endo Pharmaceuticals Solutions Inc.S Sale	Director	SSale	−42K sh	$7.19	−$302K	13,010
2004-10-01	Endo Pharmaceuticals Solutions Inc.Stock option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	$2.38	−$119K	50,000
2004-04-23	CINCINNATI BELL INCOption to BuyA Award	Director	AAward	+9,000 sh	—	—	9,000
2004-04-18	CINCINNATI BELL INCOption to BuyD Disposition to Issuer	Director	DDisposition to Issuer	−4,000 sh	—	—	0
2004-01-12	AEOLUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+6,000 sh	$0.04	+$210	7,000
2004-01-12	AEOLUS PHARMACEUTICALS, INC.Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,000 sh	—	—	0
2004-01-02	CINCINNATI BELL INCPhantom SharesA Award	Director	AAward	+1,500 sh	$5.05	+$7,575	25,895.621
2003-11-13	PRAECIS PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2003-11-06	MGI PHARMA INCM Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$10.01	+$50.1K	6,000
2003-11-06	MGI PHARMA INCM Exercise/Conversion	Director	MExercise/Conversion	+1,875 sh	$7.10	+$13.3K	7,875
2003-11-06	MGI PHARMA INCS Sale	Director	SSale	−200 sh	$37.49	−$7,498	7,675
2003-11-06	MGI PHARMA INCS Sale	Director	SSale	−1,105 sh	$37.48	−$41.4K	6,570
2003-11-06	MGI PHARMA INCS Sale	Director	SSale	−1,500 sh	$37.40	−$56.1K	5,070
2003-11-06	MGI PHARMA INCS Sale	Director	SSale	−100 sh	$37.39	−$3,739	4,970
2003-11-06	MGI PHARMA INCS Sale	Director	SSale	−1,000 sh	$37.37	−$37.4K	3,970
2003-11-06	MGI PHARMA INCS Sale	Director	SSale	−200 sh	$37.35	−$7,470	3,770
2003-11-06	MGI PHARMA INCS Sale	Director	SSale	−300 sh	$37.33	−$11.2K	3,470
2003-11-06	MGI PHARMA INCS Sale	Director	SSale	−1,000 sh	$37.32	−$37.3K	2,470
2003-11-06	MGI PHARMA INCS Sale	Director	SSale	−900 sh	$37.31	−$33.6K	1,570
2003-11-06	MGI PHARMA INCS Sale	Director	SSale	−300 sh	$37.27	−$11.2K	1,270
2003-11-06	MGI PHARMA INCS Sale	Director	SSale	−270 sh	$37.25	−$10.1K	1,000
2003-11-06	MGI PHARMA INCDirector Stock Option - Right to BuyM Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	$10.01	−$50.1K	5,000
2003-11-06	MGI PHARMA INCDirector Stock Option - Right to BuyM Exercise/Conversion	Director	MExercise/Conversion	−1,875 sh	$7.10	−$13.3K	5,625
2003-11-06	MGI PHARMA INCS Sale	Director	SSale	−200 sh	$37.49	−$7,498	7,675
2003-11-06	MGI PHARMA INCS Sale	Director	SSale	−1,105 sh	$37.48	−$41.4K	6,570
2003-11-06	MGI PHARMA INCS Sale	Director	SSale	−1,500 sh	$37.40	−$56.1K	5,070
2003-11-06	MGI PHARMA INCS Sale	Director	SSale	−100 sh	$37.39	−$3,739	4,970
2003-11-06	MGI PHARMA INCS Sale	Director	SSale	−1,000 sh	$37.37	−$37.4K	3,970
2003-11-06	MGI PHARMA INCS Sale	Director	SSale	−200 sh	$37.35	−$7,470	3,770
2003-11-06	MGI PHARMA INCS Sale	Director	SSale	−300 sh	$37.33	−$11.2K	3,470
2003-11-06	MGI PHARMA INCS Sale	Director	SSale	−1,000 sh	$37.32	−$37.3K	2,470
2003-11-06	MGI PHARMA INCS Sale	Director	SSale	−900 sh	$37.31	−$33.6K	1,570
2003-11-06	MGI PHARMA INCS Sale	Director	SSale	−300 sh	$37.27	−$11.2K	1,270
2003-11-06	MGI PHARMA INCS Sale	Director	SSale	−270 sh	$37.25	−$10.1K	1,000
2003-11-06	MGI PHARMA INCDirector Stock Option - Right to BuyM Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	$10.01	−$50.1K	5,000
2003-11-06	MGI PHARMA INCDirector Stock Option - Right to BuyM Exercise/Conversion	Director	MExercise/Conversion	−1,875 sh	$7.10	−$13.3K	5,625
2003-10-01	INCARA PHARMACEUTICALS CORPNon-Qualified Stock Option (right to buy)A Award	Director	AAward	+107K sh	—	—	107,142
2003-04-29	CINCINNATI BELL INCOption to Buy (1)A Award	Director	AAward	+9,000 sh	—	—	—
2003-01-02	CINCINNATI BELL INCPhantom Shares (2)A Award	Director	AAward	+1,500 sh	—	—	—
2002-04-29	CINCINNATI BELL INCOption to Buy (1)A Award	Director	AAward	+9,000 sh	—	—	—
2002-01-02	CINCINNATI BELL INCPhantom Shares (2)A Award	Director	AAward	+1,500 sh	—	—	—

Recent filings

Accepted (ET)
Jan 244
MGI PHARMA INC0001181431-08-005105
SEC(opens sec.gov)
May 94
MGI PHARMA INC0001181431-07-030862
SEC(opens sec.gov)
May 24
SHARROCK DAVID B0001180679-06-000002
SEC(opens sec.gov)
May 34
CINCINNATI BELL INC0001180679-05-000003
SEC(opens sec.gov)
Jan 44
SHARROCK DAVID B0001180679-05-000001
SEC(opens sec.gov)
Oct 54
SHARROCK DAVID B0001181431-04-046746
SEC(opens sec.gov)
Apr 264
SHARROCK DAVID B0001180679-04-000005
SEC(opens sec.gov)
Jan 144
SHARROCK DAVID B0001187233-04-000002
SEC(opens sec.gov)
Jan 54
SHARROCK DAVID B0001180679-04-000001
SEC(opens sec.gov)
Nov 134
SHARROCK DAVID B0001214937-03-000003
SEC(opens sec.gov)
Nov 64/A
SHARROCK DAVID B0001180679-03-000006
SEC(opens sec.gov)

Companies

Address

201 EAST FOURTH STREET

CINCINNATI, OH, 45202